Inspection Record

Agrisan Specialty Chemical & Pharmaceutical a division of Agrisan Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-02-23 11 findingsContamination controlEquipment and facilityOther quality systemValidation and qualificationDeviation, CAPA, and investigationMaterial and supplier controlComplaint and recall handlingRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

2Equipment and facility

The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.

3Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

4Validation and qualification

The qualification and/or verification of utilities and/or support systems was inadequate.

5Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

6Equipment and facility

Materials, bulk containers, major items of equipment, and/or the rooms were not properly identified.

7Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

8Material and supplier control

The protection of products and/or materials from contamination was inadequate.

9Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

10Material and supplier control

The identification, quarantine, and/or disposal of rejected materials was inadequate.

11Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-02-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Agrisan Specialty Chemical & Pharmaceutical a division of Agrisan Inc. company profile — full history Health Canada documents, 2022 Go to Findings search